论文信息 - Updated phase I trial of anti-LAG-3 or anti-CD137 alone and in combination with anti-PD-1 in patients with recurrent GBM. - 字舞流文

Updated phase I trial of anti-LAG-3 or anti-CD137 alone and in combination with anti-PD-1 in patients with recurrent GBM.

P. Wen | M. Ahluwalia | S. Grossman | S. Desideri | L. Nabors | X. Ye | M. Lim | A. Desai | C. Jackson | J. Fisher | Z. Belcaid | T. Walbert | Anna F Piotrowski